Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
Authors
Keywords
Proton pump inhibitor, Metastatic breast cancer, Chemotherapy, Time to progression (TTP), Overall survival (OS)
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 34, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-08-21
DOI
10.1186/s13046-015-0194-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of Proton Pump Inhibitors as Adjunct Treatment for Triple-Negative Breast Cancers. An Introductory Study
- (2016) Wayne Goh et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial
- (2015) Xi-Chun Hu et al. LANCET ONCOLOGY
- Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion
- (2014) Shangrong Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
- (2014) Un-Ho Jin et al. BMC CANCER
- Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer
- (2014) Jian Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer
- (2014) Kirsten Lindner et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors
- (2014) Enrico P Spugnini et al. Journal of Translational Medicine
- Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin
- (2014) Cristina Federici et al. PLoS One
- Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis
- (2013) Siddharth Singh et al. GUT
- Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
- (2013) Stefano Ferrari et al. Journal of Translational Medicine
- V-ATPase inhibition overcomes trastuzumab resistance in breast cancer
- (2013) Karin von Schwarzenberg et al. Molecular Oncology
- Docetaxel–cisplatin might be superior to docetaxel–capecitabine in the first-line treatment of metastatic triple-negative breast cancer†
- (2012) Y. Fan et al. ANNALS OF ONCOLOGY
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
- (2012) A. Calcinotto et al. CANCER RESEARCH
- Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer
- (2012) Ali I. Shamseddine et al. CHEMOTHERAPY
- Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus
- (2012) Florine Kastelein et al. Clinical Gastroenterology and Hepatology
- Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo
- (2012) Min Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump
- (2012) S Fan et al. ONCOGENE
- Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors
- (2011) Enrico P Spugnini et al. Journal of Translational Medicine
- Omeprazole Inhibits Proliferation and Modulates Autophagy in Pancreatic Cancer Cells
- (2011) Andrej Udelnow et al. PLoS One
- Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
- (2010) Johanna Chiche et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy
- (2010) Enrico P Spugnini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism
- (2010) S. Fais JOURNAL OF INTERNAL MEDICINE
- Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells
- (2009) Haiyan You et al. CANCER LETTERS
- Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
- (2009) I. F. Robey et al. CANCER RESEARCH
- Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells
- (2009) Min Chen et al. CELL BIOLOGY INTERNATIONAL
- Proton pump inhibitors: actions and reactions
- (2009) James M. Mullin et al. DRUG DISCOVERY TODAY
- Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation
- (2009) Kelly M Kennedy et al. Future Oncology
- pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
- (2009) Angelo De Milito et al. INTERNATIONAL JOURNAL OF CANCER
- Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells
- (2009) Isabella Parolini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
- (2009) Mariantonia Logozzi et al. PLoS One
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment
- (2008) Kathy S. Albain et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search